WO2021071977A1
|
|
In vitro methods and compositions for enhancing the activation of dendritic cells and t cells, and for inducing a th-1 immune response
|
AU2016228284A1
|
|
Administration of dendritic cells partially matured in vitro for the treatment of tumors
|
WO2017048875A1
|
|
Methods relating to activated dendritic cell compositions and immunotherapeutic treatments for subjects with advanced cancers
|
MX2018000056A
|
|
Optimally activated dendritic cells that induce an improved or increased anti-tumor immune response.
|
AU2013234394A1
|
|
Administration of dendritic cells partially matured in vitro for the treatment of tumors
|
AU2013206016A1
|
|
Compositions and methods for inducing the activation of immature monocytic dendritic cells
|
AU2013201707A1
|
|
Compositions and methods for priming monocytic dendritic cells and T cells for Th-1 response
|
AU2011218747A1
|
|
Tangential flow filtration devices and methods for stem cell enrichment
|
AU2006321794A1
|
|
Compositions and methods for inducing the activation of immature monocytic dendritic cells
|
US2005189297A1
|
|
Tangential flow filtration devices and methods for stem cell enrichment
|
BRPI0407900A
|
|
generation of dendritic cells from gm-csf monocytic dentitic precursor cells in the absence of additional cytokines
|
WO2004072262A2
|
|
Cultured cd14+ antigen presenting cells
|
US2004197903A1
|
|
Method for induction of proliferation of natural killer cells by dendritic cells cultured with GM-CSF and IL-15
|
CA2509058A1
|
|
Administration of dendritic cells partially matured in vitro for the treatment of tumors
|
NZ537188A
|
|
Tangential flow filtration devices and methods for leukocyte enrichment
|
US2006234309A1
|
|
Quality assays for antigen presenting cells
|
IL155793D0
|
|
Monoclonal antibodies having an antigen binding region specific for the extracellular domain of prostrate specific membrane antigen (psma)
|
IL160720D0
|
|
Composition and methods for priming monocytic dendritic cells and t cells for th-1 response
|
AU2002326463A1
|
|
Methods and apparatus for enrichment and culture of monocytic dendritic cell precursors
|
AU2002252160A1
|
|
Connexin enhances chemotherapy-induced apoptosis in human cancer cells inhibiting tumor cell proliferation
|